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 
Abstract—We have created a novel chip-based diagnostic tools 
based upon quantification of metabolites using enzymes specific 
for their chemical conversion. Using this device we show for the 
first time that a solid-state circuit can be used to measure enzyme 
kinetics and calculate the Michaelis-Menten constant. Substrate 
concentration dependency of enzyme reaction rates is central to 
this aim. Ion-sensitive field effect transistors (ISFET) are 
excellent transducers for biosensing applications that are reliant 
upon enzyme assays, especially since they can be fabricated using 
mainstream microelectronics technology to ensure low unit cost, 
mass-manufacture, scaling to make many sensors and 
straightforward miniaturisation for use in point-of-care devices. 
Here, we describe an integrated ISFET array comprising 216 
sensors. The device was fabricated with a complementary metal 
oxide semiconductor (CMOS) process. Unlike traditional CMOS 
ISFET sensors that use the Si3N4 passivation of the foundry for 
ion detection, the device reported here was processed with a layer 
of Ta2O5 that increased the detection sensitivity to 45 mV/pH unit 
at the sensor readout. The drift was reduced to 0.8 mV/hour with 
a linear pH response between pH 2 – 12. A high-speed 
instrumentation system capable of acquiring nearly 500 fps was 
developed to stream out the data. The device was then used to 
measure glucose concentration through the activity of hexokinase 
in the range of 0.05 mM – 231 mM, encompassing glucose’s 
physiological range in blood. Localised and temporal enzyme 
kinetics of hexokinase was studied in detail. These results present 
a roadmap towards a viable personal metabolome machine.  
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I. INTRODUCTION 
NZYMES are natural catalysts that accelerate the rate of 
chemical reactions in order to sustain life [1]–[6]. Since 
their discovery, enzymes have been increasingly exploited for 
commercial purposes such as in foods [7], detergents [8], and 
healthcare [9]. Most enzymes catalyse reactions following 
kinetics that are described by the Michaelis-Menten equation 
[1]–[6]. The rate of an enzyme’s activity depends on its 
substrate concentration, hence measurements of enzyme 
activity can be used to determine a concentration of its 
substrate. The KM value is the substrate concentration ([S]) at 
which the reaction rate is half the maximum velocity (υmax) of 
the reaction [1]–[4].  
 
 
υ υ   
   
      
 (1) 
 
By understanding the KM of enzymes, the rate and sensitivity 
of a wide range of biosensing and diagnostic devices can be 
greatly improved, including potential application in 
metabolomics.  
Many enzymes consume or produce protons as part of their 
reaction pathway.  It is therefore possible to perform enzyme 
assays using an electrochemical sensor such as an Ion-
Sensitive Field Effect Transistor (ISFET). The ISFET was first 
proposed by Bergveld [10], and the first practical application 
was to measure a penicillin [11]. The ISFET, a potentiometric 
device [12], measures the hydrogen concentration dependent 
surface potential when exposed to an aqueous solution, with 
respect to a reference electrode [13]. The earliest devices were 
made using specialist one-off processes, but more recently 
research has shown that good devices can be made using 
standard complementary metal oxide semiconductor processes 
[14].  Further work led to the implementation of arrays of 
sensors, much like a camera using photodiodes [15], [16]. 
Using these devices it has been possible to show that chemical 
imaging using sensor signal variation as the image contrast 
mechanism is possible. 
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The array format also presents possibilities for improving 
overall system performance, which we exploit in this paper. 
As will be shown, if instead of one single sensor channel, we 
use multiple independent sensor channels with uncorrelated 
noise in each. Averaging over more than one sensor leads to a 
significant improvement in noise, hence effective sensitivity. 
To thoroughly explore this possibility a very large array of 2
16
 
sensors has been deployed. 
All ISFETs rely on a so-called dielectric membrane (an 
insulator). In solution a charge double-layer is formed as 
hydrogen or hydroxyl ion species, according to pH, adsorb on 
to the surface forming a static charge layer. Charge 
equilibrium across the dielectric to the nearest floating gate 
electrode produces a localised and detectable signal on each 
sensor in an array. The sensitivity varies depending on the 
exact dielectric used. Several materials have been studied, 
including SiO2, Si3N4, Al2O3, SnO2, ZrO2, and Ta2O5 [17]–
[21]. Ta2O5 has proven to be an excellent material with good 
immunity against interference ions and a wide working pH 
range [22]. 
Using only a single ISFET sensor, various enzymes such as 
urease [22], [23], creatinine deiminase [24], and glucose 
oxidase [25] have been used to modify the surface of the 
ISFET gate to be sensitive towards a specific substrate. 
Nevertheless, enzyme kinetics (i.e. the change in velocity of 
the reaction catalysed by the enzyme as a function of substrate 
concentration) has not previously been studied using an 
ISFET-based sensor. 
Three different enzymes have been widely used for glucose 
measurements: hexokinase, glucose oxidase (GOx) and 
glucose-1-dehydrogenase (GDH) [9]. Commercial glucose 
biosensors use GOx or GDH as the bioreceptor for the rapid 
analysis of blood glucose levels, informing the patient of his 
or her glycaemic status [9], [26]. Hexokinase is the first 
enzyme in glycolysis used to convert glucose into energy in 
the form of adenosine triphosphate (ATP) [27], and has been 
extensively studied in clinical laboratories using 
spectrophotometry as a reference method for glucose 
measurements [9].  
In order to create a new and quantifiable measurement 
system for enzyme assays based on ISFETs, we have 
developed a new CMOS sensing array to provide speed and 
multiple data from which data can be accurately determined. 
We describe the kinetic analysis of hexokinase on the CMOS 
ISFET array and also a new approach using this enzyme for 
direct glucose measurements. The chip, which was fabricated 
in the AMS 0.35 µm four metal CMOS process, consists of an 
array of 256  256 pixels. These pixels were subsequently 
post-processed with a Ta2O5 layer to improve the longevity, 
reduce drift, and increase the sensitivity of the sensor. 
Spectrophotometric assays were initially used to determine the 
activity of hexokinase supplied in solution to the chip. The 
response of hexokinase to its substrate (glucose) at various 
concentrations caused a voltage change corresponding to the 
production of hydrogen ions from the reaction, validating the 
assay as a means of direct glucose measurement. Using the 
measured data, the Michaelis-Menten constant (KM) of 
hexokinase on the chip was calculated using the maximum 
dV/dt, where V is the ISFET signal voltage. Using the array 
function of the chip, we have explored the effect of averaging 
over different numbers of sensors, and its impact on the noise 
performance of the system. Hexokinase was thus validated as 
an enzyme capable of being used to determine glucose levels 
on ISFETs. 
The work in this paper will promote future research towards 
the implementation of multiple assays on a single chip format. 
Such a device has the potential to produce personalised 
metabalomic measurements that are now becoming central to 
the development of precision and stratified medicine [28], 
[29]. 
II. MATERIALS AND METHODS 
A. 256  256 ISFET Array Chip 
The ISFET sensor array chip was fabricated in a commercial 
foundry (Austriamicrosystems, Austria) using the standard 
0.35 µm, four metal process. As shown in Fig. 1a, each pixel 
comprises 4 transistors, where P2 is a PMOS ISFET transistor 
configured as a voltage-follower for hydrogen ion 
concentration detection, P1 is an in-pixel current source for 
P2, and P3 and N1 form a transmission gate for addressing 
using  col and  col̅̅ ̅̅ ̅ [16].  The size of each pixel is 10.2 µm  
10.2 µm, so that the entire array occupies an area of 
approximately 2.87 mm  2.87 mm. An atomic force 
micrograph of a single pixel and an optical micrograph of the 
whole array are also shown in Fig. 1. The corrugated surface 
profile that can be seen in Fig. 1b arises from the top-metal 
electrode layout. Our devices show variation in the sensor 
threshold voltage with a standard deviation of 0.238 V. 
However we study time response measurements where static 
offsets are eliminated. 
Fig. 2 illustrates the architecture for reading all 256  256 
pixels from the chip. The sensor array is divided into two 
halves of 256 rows and 128 columns. An identical but separate 
row multiplexing system and column decoder is used for each 
half. The 7-bit column decoders select one column from the 
128. The row data is broken down into 4 pairs of parallel 
blocks of 32 analog signals at each side. The blocks are read-
out sequentially via a 1 from 8 multiplexer. 
 
B. Post-Processing of the CMOS Chip 
The cross-section shown in schematic form of a pixel, 
illustrating the semiconductor, metal and dielectric layers, is 
shown in Fig. 3. The metal layout in each pixel uses a metal-
via stack to contact the underlying transistor to the top metal 
layer (MET 4) beneath the dielectric passivation layer. The 
MET 4 plate therefore forms a capacitor with the analyte 
above the chip [16]. The dielectric in contact with MET 4 acts 
as an ion sensing material which translates the hydrogen ion 
concentration in the analyte to a voltage at the polysilicon gate 
of the ISFET according to the Nernst equation. This voltage is 
detectable as a gate threshold shift in the MOSFET. A 
reference electrode with a fixed potential is required. Without 
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further processing, the device can be used for pH sensing with 
the native passivation of the CMOS process, Si3N4, which is 
known to show a sub-Nernstian response. Typical responses 
are 46 mV/pH [30]. Alternatively, the device may be coated 
with another dielectric, such as Ta2O5, which has been shown 
to give a response as large as 58 mV/pH [21]. The Ta2O5 is a 
thin insulator and therefore does not modify the cross-talk 
properties of the individual sensors that have previously been 
shown to be capable of forming images [16]. 
Using a photomask and photolithography to open a window 
over the active area of the sensor array, a 100 nm Ta2O5 layer 
was deposited on top of the array passivation using a radio 
frequency sputtering tool (Plassys, France). We chose to use a 
100 nm thick Ta2O5 film because it was found by 
experimentation to give consistent coverage over the 
topographically varying surface. The resist was then stripped, 
leaving the Ta2O5 over the array only, using the lift-off 
technique. A ceramic Ta2O5 target was used for sputter coating 
with a RF power of 300 W, and a gas mixture ratio (Ar:O2) of 
9:1 at room temperature. The working pressure was 100 µbar. 
It has been shown that an optimised process can deposit films 
with an ideal surface stoichiometric ratio and good surface 
roughness [31]–[33]. As shown in Fig. 4, the sputtering 
conditions that were used in this work yielded a Ta2O5 film 
with an average surface roughness of 0.42 nm and surface 
chemical atomic ratio (Ta:O) of 1:1.76. The surface roughness 
is comparable to earlier work. However, the surface chemical 
atomic ratio is lower than the ideal stoichiometric value of 
1:2.5 [31]. A high temperature and pure oxygen atmosphere is 
incompatible with both the fabrication technique and CMOS 
technology. As a compromise, the conditions we used allow 
some oxygen to leech out of the surface during sputtering, 
affecting the surface stoichiometric ratio. Nevertheless, as will 
be described, we obtained a significant improvement in device 
performance. 
 
C. Chip Packaging  
Prior to performing aqueous measurements, an 
encapsulation sealant was required to protect the bond pads 
and wire bonds. Fig. 5 shows the packaging and encapsulation 
technique used to achieve this protection while leaving the 
sensor active area exposed. The chip was mounted onto a 
PGA-144 chip carrier by applying EPO-TEK H74 epoxy to 
the back-side of the die. The epoxy was then cured at 150 °C 
for 10 minutes, bonding the chip to the chip carrier. The chip 
pads were then wire bonded to the chip carrier. Next, a 3 mm 
square Polydimethylsiloxane (PDMS) cube was placed on top 
of the sensor array (thus protecting the sensor area from the 
epoxy) and EPO-TEK 302-3M epoxy was used to encapsulate 
the bond pads and wire bonds. A PDMS cube was used for 
protection because of its ability to adhere to the surface 
without any adhesive and the ease of removal. The epoxy was 
cured at room temperature for 24 hours. The long room 
temperature cure time eliminates the risk of the epoxy, the 
viscosity of which reduces at higher temperature, leaking 
underneath the PDMS cube. The PDMS cube was then peeled 
off to create a cavity over the sensor array. A polypropylene 
centrifuge tube from Fisherbrand was cut and fitted on top of 
the chip carrier using epoxy to contain the necessary 
experimental fluids. This packaging technique has proven to 
be very robust. It is easily repeated from chip-to-chip and once 
a chip has been packaged, a great many enzyme assays can be 
performed on the same chip without damage to the underlying 
electronics. 
 
D. Instrumentation and Measurement System  
To operate the sensor array chip, a high-speed 
instrumentation and measurement system was constructed to 
acquire the pixel voltages (representing the local pH value) 
and to provide the digital address signals to the chip. For 
enzyme kinetics measurements, the speed of the measurement 
tool was designed to operate up to a maximum speed of 
2 µs/pixel. This maximum acquisition rate translates to 
2.048 milliseconds per frame, which equates to just under 500 
frames per second, although this ability is not fully used in this 
paper 
The instrumentation and measurement system consists of a 
computer, four PXI-Express-6358 X series acquisition cards in 
a PXI-Express-1073 chassis (National Instruments, UK), a 
custom printed circuit board (Newbury Electronics, UK) and a 
packaged chip. An external voltage source was connected to a 
Ag/AgCl quasi-reference electrode [34] which was dipped into 
the centrifuge tube on top of the chip containing an aqueous 
solution. The Ag/AgCl quasi-reference electrode was formed 
by immersing Ag wire in 0.1 M KCl and then biasing it at 
1.3 V using a potentiostat for 2 minutes. The reference 
electrode was used in the aqueous solution to set the floating 
gate potential of all the ISFET sensors in the array.  
The PXI-Express chassis was connected to a computer with 
a PCI Express-8361 card. A PGA ZIF 15  15 socket was used 
to house the chip carrier in the PCB. The PCB connects all 64 
analog outputs from the chip to the 16 analog inputs of each 
acquisition card. In addition, the PCB also connects 10 digital 
outputs from one of the cards to all the respective address 
inputs on the chip. All the digital outputs from the card are in 
the range of 0 – 5 V. Two MAX 3001 E voltage level shifters 
were used to lower the voltage to a range of 0 – 3.3 V to be 
compatible with the power supply of the chip. Besides 
connecting all the analog outputs and digital inputs, the PCB 
also connects a 1 V voltage source to the gate of every in-pixel 
load transistor (P1 in Fig. 1a) of the chip.  
The whole operation of the system was controlled by the 
software package LabVIEW that was programmed to read 64 
analog outputs from the chip and also send the 10-bit of digital 
addresses to activate the chip. It is very important to 
synchronise the digital addressing and the analog data, in 
order to obtain the correct pixel measurement as a function of 
time. This was done with the PXI-Express reference clock 
where both the digital addresses and analog data (at half the 
period of sampling rate) were synchronised.  
For a high speed data storage system, the direct memory 
access (DMA) feature of the PXI-Express-6358 X series 
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acquisition cards and solid state drive (SSD) of the PC was 
used to send digital addresses and receive analog data 
respectively. Using this strategy, the system operated 
independently of the central processing unit and operating 
system. It was therefore possible to offer continuous 
addressing without interruptions and for large volumes of data 
to be transferred to the SSD at 60 MB/s as a National 
Instruments standard TDMS file.  
For real time analysis and measurement, LabVIEW was 
used to arrange all the data into frames of 65536 pixels. The 
data was then used for 2D and 3D image representation, as 
well as data analysis of individual pixels. 
 
E. Chemicals  
For the hexokinase assays, the following reagents were 
used. Hexokinase and glucose-6-phosphate dehydrogenase 
(G6PDH), both purified from Saccharomyces cerevisiae, were 
purchased from Sigma-Aldrich. Adenosine 5’-triphosphate 
(ATP) disodium salt and triethanolamine hydrochloride were 
also sourced from Sigma-Aldrich. β-Nicotinamide adenine 
dinucleotide phosphate (β-NADP) was purchased from 
Applichem, D-glucose from Fisher Scientific, and magnesium 
chloride hexahydrate from VWR.  
Phosphate buffer at pH 7 was purchased from Sigma-
Aldrich for washing steps. Solutions of defined pH (pH 1 – 
14) were made with hydrochloric acid and sodium hydroxide. 
Buffered pH 4 and pH 10 solutions were bought from Fisher 
Scientific to characterise the chip sensitivity. 
III. RESULTS AND DISCUSSION 
A. pH Sensitivity, Range and Drift 
The functionality and pH response of the ISFET sensors 
were initially tested to demonstrate the ability to detect 
hydrogen ions using different pH solutions ranging from pH 1 
– 14, prepared from 1 M hydrochloric acid (pH 0) and 1 M 
sodium hydroxide (pH 14). Experiments were conducted by 
adding first either the alkali or the acid to the chip and then 
modifying the pH by titrating the acid or alkali accordingly, on 
to the chip. At each titration point the pH solution was 
measured for 2 minutes to obtain a stable result. Deionised 
water was used to clean and rinse the sensor between each pH 
measurement. Measurements were taken two times with 
descending pH and once with increasing pH using the same 
chip to validate that the sensor was able to detect a wide pH 
range with good uniformity across the sensor array. The data 
is shown in Fig. 6. The pH sensitivity is approximately 
45 mV/pH and yields a near linear voltage response between 
pH 2 – 12. We noted that this is less than the potential 
58 mV/pH for Ta2O5. The signal loss may be due to the non-
stoichiometric nature of the Ta2O5 we deposited or attenuation 
in the voltage-follower circuit of each pixel. 
Besides sensitivity and a wide working pH range, the Ta2O5 
sensing layer has an additional advantage: the constant signal 
drift of Ta2O5 ISFET is approximately only 0.8 mV/hour, as 
shown in Fig. 7, as compared to 10 mV/hour [17] for the Si3N4 
passivation layer of the chip when used as a pH sensor. 
Buffered pH 7 solutions were used for these drift 
measurements. The solution was added and measurements 
were taken for up to 2.5 hours. The measurement of the drift 
was taken from the average of the whole sensor array. This 
low drift value allows this sensor to be used for stable assay 
measurements, unlike other ISFET devices which can suffer 
from significant levels of drift [17], [30], since our 
measurements only require 15 minutes to acquire sufficient 
enzyme response data. The chip is also very robust and each 
sensor can be reused several times. 
 
B. Signal Noise and Number of Pixels 
Our measurements produce a complete independent data set 
for all pixels. Using the array we can take data from a single 
pixel, or we can average data from 2 to 2
16
 pixels. The effect 
of averaging is to reduce the mean square (MS) noise of the 
combined assay signal. To illustrate, in Fig. 8 we show a 
typical time-course from the chip for a small concentration of 
glucose. In this example, it can be seen for the data taken from 
a single pixel, the noise is very large. However, if we plot the 
data obtained by averaging the signal from 2
16
 pixels in the 
array, then the noise is much reduced. We have analysed this 
characteristic of the system in detail. 
For any single pixel in the array, the voltage signal, 
including its noise component is Vi. The MS voltage noise is 
ei
2
. For a data sample in the interval from time t1 to t2, ei
2
 is 
calculate using, 
 
 
  
  
 
     
∫   
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The interval t1 to t2 is chosen to be a region of data where the 
signal is not changing. When the signal is averaged for M 
independent pixels, the average signal is calculated to be, 
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We can therefore calculate the noise for the average voltage 
VM(t) using (2). The results of this analysis are presented in 
Fig. 9, where we plot the MS noise as a function of 
 
√ 
. As can 
be seen the graph is very nearly linear, which is what we 
expect from Gaussian statistics. 
Using this data, we are able to make practical decisions 
about the number of pixels required to make usable 
measurements for the assay conditions we have chosen. For 
the substrate glucose concentration we described, chosen to be 
the physiological range for in human blood. We found that 5 
pixels provide adequate data. 
Using the array chip, we can program the number of pixels 
used and therefore target different substrate concentrations. 
Table I shows the physiological range of glucose in different 
body fluids. Whilst standard practice today is to measure 
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blood glucose, a more sensitive system may be able to perform 
the assay reliably in other fluids such as urine or tears. 
However, glucose is not a functional substrate in either urine 
or tears, so further clinical study would be required to 
determine the efficacy of such an approach. 
 
 
 
C. Spectrophotometric Measurement of Hexokinase Activity  
The enzymatic activity of hexokinase evaluated using a 
coupled reaction with G6PDH is the reference method for 
measuring glucose by spectrophotometry. The reactions are 
shown in (4).  
 
   lucose A  
 e        
→          lucose     A      
(4) 
   lucose     β  A  
     
→         β  A       
 
where D-Glucose-6-P is D-Glucose-6-Phosphate, ADP is 
Adenosine 5’-Diphosphate, 6-PG is 6-Phospho-D-Gluconate 
and β- A   is β-Nicotinamide adenine dinucleotide 
phosphate. 
Prior to commencing experimental studies using the ISFET 
array, laboratory verification of hexokinase activity was 
carried out using a classical assay by monitoring β-NADPH 
production using a UV-2550 Spectrophotometer (Shimadzu, 
Japan) at 340 nm and 25 °C. The concentrations of each 
reagent in 1.26 ml solution were as follows: 20 mM 
triethanolamine buffer pH 8.5, 219 mM glucose, 7.9 mM 
MgCl2, 1.1 mM β-NADP, 0.7 mM ATP, 1.25 Units G6PDH 
and 0.02 – 5 Units hexokinase. A Unit of hexokinase activity 
is defined to be the amount of hexokinase required to 
phosphorylate 1 µmol of glucose per minute under standard 
conditions. Different Units of hexokinase were titrated to 
determine the optimal amount to use for subsequent 
experiments. The progress curves that were generated gave 
suitable kinetics at between 0.125 and 5 Units on the 
spectrophotometer. 
The Michaelis-Menten constant was determined by 
incubating 2.5 Units of hexokinase with glucose 
concentrations in the range of 0.2 mM – 22 mM. Each 
progress curve shows a rapidly rising (linear) signal before 
reaching saturation. From the progress curves, the initial 
velocity (covering the linear part of the progress curve for 
each substrate concentration) was plotted versus the substrate 
concentration and GraphPad Prism, which has a built-in 
Michaelis-Menten algorithm, was used to calculate the value 
of KM, which was 0.85 mM. The data is shown in Fig. 10. 
 
D. Enzyme Kinetics Measurement on Chip 
For the on-chip assay, the reagents used for the above 
spectrophotometer evaluation were simplified, since there is 
no need to couple the reaction with G6PDH so as to detect the 
production of β-NADPH. The second reaction in (4) could 
therefore be eliminated. Instead the production of protons is 
measured directly as a pH change using an ISFET. 
Routinely, enzyme assays employ a buffer system to 
sequester fluxes in protons in order to maintain an optimum 
pH range for the enzyme. Thus, the concentration of the buffer 
plays a crucial role towards the sensitivity of an assay that 
measures a change in pH. Moreover, it is also essential that 
reaction components do not alter the pH intrinsically prior to 
initiation of the enzyme reaction. Therefore, before testing on 
the ISFET, reaction conditions were rigorously tested using a 
S  0 SevenCompact™ p /Ion meter (Mettler-Toledo, USA) 
in order to optimise conditions and maximise sensitivity. A 
lowering of pH was evident when all hexokinase reaction 
components were added to the assay under optimised 
conditions (data not shown). 
The ISFET sensor detects differences in local pH caused 
during an enzyme reaction allowing determination of the 
Michaelis-Menten constant. To maximise the sensitivity of the 
measurement of enzyme activity on an ISFET sensor, the 
triethanolamine buffer concentration was reduced from 
22 mM to 2.2 mM, which was sufficient to maintain the pH of 
the solution within the optimum pH range of the hexokinase 
(pH 7.5 – 9.0), allowing for a detectable increase in the 
voltage of the ISFET sensor. 
The starting pH of the buffer was chosen to be 8.5; this is at 
the high end of the desired operating range for the enzyme, 
since the pH falls in the course of the reaction. The pH of the 
ATP solution was adjusted from pH 3.5 to pH 8.5 by titrating 
with 1 M sodium hydroxide thus preventing an intrinsic 
reduction of p  below the enzyme’s working range. 
The data for all experiments present in this paper was 
acquired from the same chip to ensure consistency. The chip 
was cleaned thoroughly with phosphate buffer solution and 
blown dry with a high pressure nitrogen gun between each 
experiment. We also demonstrated to our satisfaction that two 
more chips performed to the same standard and function. For 
the three chips we measured, there was a slight chip-to-chip 
variation in performance of approximately 1 mV in the signal 
voltage when measuring the response to the addition of a 
0.7 mM substrate. Complete datasets were obtained from each 
of the chips. For the data acquired in Fig. 11, two 1 ml 
solutions were prepared with reagent concentrations as 
follows: (solution A) 22 mM triethanolamine buffer pH 8.5, 
239 mM glucose, 8.6 mM MgCl2 and 2 Units hexokinase; 
(solution B) 2.2 mM triethanolamine buffer pH 8.5, 239 mM 
glucose, 8.6 mM MgCl2 and 2 Units hexokinase. As an aid to 
checking our work, 43 µg/ml phenol red was added to each 
solution to provide a visual pH indicator. Experiments were 
then conducted by varying the concentration and pH of ATP 
and testing for hexokinase activity. Additional control 
experiments were carried out whereby hexokinase was 
replaced with bovine serum albumin (BSA) as a non-
enzymatic protein control. Fig. 11a shows the results obtained 
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when the buffer concentration was 22 mM and Fig. 11b shows 
the results when the buffer concentration was reduced to 2.2 
mM.  
As can be seen, the response to changing conditions of ATP 
and pH is greater with 2.2 mM buffer, showing proton 
detection is higher at the lower buffer concentration. 
Additionally, there is little or no positive response when BSA 
was used in place of hexokinase. With the reaction conditions 
optimised, an experiment was carried out to test the sensitivity 
to varying concentrations of glucose in the known 
physiological range. By doing so, the KM of hexokinase on the 
ISFET chip could be derived. The range of glucose 
concentrations tested (between 0.05 mM – 231 mM) 
encompassed the physiological range of blood glucose, from 
2.8 mM (hypoglycaemia) to 20 mM (extreme hyperglycaemia) 
[41]–[44]. As can be seen in Fig. 12a, the signal from a typical 
single pixel (pixel X) rises towards a fixed voltage plateau that 
varies as a function of the glucose concentration in the analyte. 
Fig. 12b shows the average signal as a function of time for 
N = 5 pixels selected from the chip. This procedure reduces 
the voltage signal noise by √  as would be expected to be 
1.1 mV, and enables the calculation of a standard deviation. At 
the voltage plateau the rate of turnover of glucose by the 
enzyme is constant for the given concentration. Since the 
turnover of glucose is directly related to the production of 
protons, and the ISFET gives a voltage signal that is linear 
with pH, we have plotted the average maximum (plateau) 
signal voltage against log [glucose] for pixel X in Fig. 12c. 
Fig. 12d shows the same plot for the average of five pixels. 
We observe that the log/lin plot has a straight-line 
dependency, as we expect, through a central operating region 
that, for the assay conditions we have used, is appropriate for 
the physiological range of glucose in blood. The plot deviates 
from the Nernstian fit at both the low and very high glucose 
concentrations. The assay is not sufficiently sensitive for the 
very lowest concentrations for the assay chemistry used, 
whereas at very high glucose concentrations, the ATP is 
completely used up by the glucose, saturating the signal. 
In Fig. 12e and 12f we show Lineweaver-Burk double 
reciprocal plots of 1/(max(dV/dt)) vs 1/[glucose] for each 
concentration that was used. As expected, these plots show a 
linear region, the intercept with the 1/[glucose] axis of which 
can be used to calculate 1/KM, by rearranging (1) as shown in 
(5).  
 
  
υ
 
  
υ   
 
   
 
 
υ   
 (5) 
 
As with the log/lin plots, the assay deviates from linear 
behaviour for very low or very high [glucose]. Using this 
method a KM value of 0.58 ± 0.36 mM for the average of the 5 
pixels was obtained. The result is in good agreement with the 
data that we obtained for the same assay using the 
spectrophotometer.  
IV. CONCLUSION 
In this paper, we have demonstrated an enzyme assay 
performed using CMOS ISFETs. Using the ISFETs, a signal 
voltage was produced that tracked the evolution of hydrogen 
ions in the hexokinase/glucose assay that we used. The data 
we obtain shows for the first time that enzyme kinetics, and 
the determination of the Michaelis-Menten constant can be 
carried out on a CMOS chip. The results are comparable to 
those obtained using a standard bench-top spectrophotometer-
based technique. 
In order to make the study of enzyme kinetics possible on a 
CMOS chip we have developed two new techniques. Using 
the ISFET array method, we were able to exploit the statistics 
of averaging signals from more than one channel to reduce the 
overall noise in the system. Improvements in the assay 
chemistry were also introduced. By adjusting the buffering of 
the reagents we have shown that we can increase the local 
variation in pH at the ISFET sensors. Using both these 
techniques, glucose concentrations in the range of 0.05 mM – 
231 mM were detected, encompassing the natural 
physiological range of glucose in blood, from 2.8 mM 
(hypoglycaemia) to 20 mM (extreme hyperglycaemia). The 
Michaelis-Menten constant was calculated to be 
0.58 ± 0.36 mM. The ISFET data we obtained is in good 
agreement with traditional spectrophotometer data, which is 
presented in this paper. 
For the hexokinase assay we performed, we found that 
using five sensors was sufficient. The ISFET device described 
here has a large array of individually addressable sensors. 
Since as few as five sensors is adequate for one assay, we 
anticipate that, by using more area of the array, sensors can be 
grouped into zones on the surface of the chip. Using this 
method, in tandem with microfluidics, different zones could 
be functionalised with different enzymes to measure several 
metabolites at the same time. In this way, the array 
architecture can provide two distinct outcomes: noise 
reduction by averaging over independent channels; and 
multiple simultaneous metabolomic assays. 
A well-known application for this device could be to 
monitor the symptoms of diabetes mellitus, a chronic 
metabolic disorder that is increasing in prevalence to an 
alarming degree, placing a heavy outlay on social and medical 
resources [44]. As interest grows in metabolomics for 
precision medicine [28], [29], the work in this paper presents a 
pathway towards new and exciting handheld diagnostic tools. 
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Fig. 1.  (a) A schematic diagram of a single pixel [16] and (b) the surface 
profile of a single pixel from an atomic force microscope. (c) A 
microphotograph of the whole of the 256  256-pixel ISFET sensor array. 
 
 
Fig. 2.  A schematic diagram of the 256  256 ISFET sensor array chip, 
describing the addressing architecture. 
 
 
Fig. 3.  A cross sectional view of the ISFET structure fabricated using the 
AMS 0.35 µm, four metal, process.  An additional Ta2O5 thin film was 
subsequently added by a post-processing step. 
 
 
 
Fig. 4.  (a) X-Ray Photoelectron Spectroscopy (XPS) analysis of the material 
composition on the Ta2O5 surface, showing the binding energy and percentage 
atomic concentrations of O 1s and Ta 4f. (b) The surface profile of the Ta2O5 
layer obtained using Atomic Force Microscopy (AFM). Ra is the average 
roughness, Rq is the RMS roughness and Rmax is the maximum roughness. 
 
 
Fig. 5.  Photographs of (a) a fully wire bonded and well encapsulated 256  
256 pixels ISFET sensor array chip showing (b) top view and (c) side view. 
 
 
Fig. 6.  pH response curve of the average sensitivity for all the 256  256 
pixels on the chip. The error bars are calculated using the standard deviation. 
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Fig. 7.  The average drift of Ta2O5 sensing layer on the whole array of the 
CMOS ISFET chip. 
 
Fig. 8.  The comparison of the signal from a typical sensor and the average of 
the whole array. 
 
Fig. 9.  The MS noise, ei
2 as a function of 1/√ , where M is the number of 
sensors we choose to average. 
 
 
Fig. 10.  The data obtained with different glucose concentrations using a 
spectrophotometer. It shows the linear maximum velocity part of the data that 
was used for Michaelis-Menten parameter calculation. 
 
 
Fig. 11.  On chip enzymatic and control measurements with different 
concentration and buffer strength of ATP solution in a final buffer 
concentration of (a) 22 mM and (b) 2.2 mM triethanolamine buffer. The 
legend applies to both Fig. 9a and Fig. 9b. 
Fig. 12.  (a) A typical single pixel data set acquired from the chip and (b) the 
average of five pixels. The legend for Fig. 10b is the same as that for Fig. 10a. 
(c) The voltage change with respect to glucose concentration for a typical 
single pixel and (d) the average of five pixels. (e) Lineweaver-Burk double 
reciprocal plot of a typical single pixel and (f) the Lineweaver-Burk plot for 
an average of five pixels.  
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